A Muller
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
Rochlitz C, Zaman K, Mayer M, Cliffe B, Herrmann R, Mannhart-Harms M, Muller A, Rauch D, Winterhalder R, von Moos R, Schonenberger A, Fehr M, Bühlmann M, Suter T, Huober J, Spirig C, Lerch S, Ruhstaller T, Swiss Group for Clinical Cancer Research (SAKK). Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). Ann Oncol 2010; 22:80-5.
01.07.2010Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
01.07.2010Ann Oncol 2010; 22:80-5
Rochlitz C, Zaman K, Mayer M, Cliffe B, Herrmann R, Mannhart-Harms M, Muller A, Rauch D, Winterhalder R, von Moos R, Schonenberger A, Fehr M, Bühlmann M, Suter T, Huober Jens, Spirig C, Lerch S, Ruhstaller Thomas, Swiss Group for Clinical Cancer Research (SAKK)
B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis
Craig V, Cogliatti S, Arnold I, Gerke C, Balandat J, Wündisch T, Muller A. B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia 2010; 24:1186-96.
01.06.2010B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis
01.06.2010Leukemia 2010; 24:1186-96
Craig V J, Cogliatti Sergio B., Arnold I, Gerke C, Balandat J-E, Wündisch T, Muller A
Management of primary breast cancer: an update
Thürlimann B, Muller A, Senn H. Management of primary breast cancer: an update. Onkologie 2004; 27:175-9.
01.04.2004Management of primary breast cancer: an update
01.04.2004Onkologie 2004; 27:175-9
Thürlimann Beat, Muller A, Senn H-J
Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis
Guldenschuh I, Spigelman A, Hoppeler T, Fried M, Meyenberger C, Roth J, Seelentag W, Flury R, Zala G, Dobbie Z, Mullhaupt B, Ammann R, Muller A, Hürlimann R, Scott R. Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Diseases of the colon and rectum 2001; 44:1090-7; discussion 1097-9.
01.08.2001Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis
01.08.2001Diseases of the colon and rectum 2001; 44:1090-7; discussion 1097-9
Guldenschuh I, Spigelman A D, Hoppeler T, Fried M, Meyenberger Christa, Roth J, Seelentag W, Flury R, Zala G F, Dobbie Z, Mullhaupt B, Ammann R, Muller A, Hürlimann R, Scott R J
[Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study]
Muller A, Hürlimann R, Meyenberger C, Staub P, Kobler E, Ammann R. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study]. Schweizerische medizinische Wochenschrift 1994; 124:651-4.
16.04.1994[Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study]
16.04.1994Schweizerische medizinische Wochenschrift 1994; 124:651-4
Muller A, Hürlimann R, Meyenberger Christa, Staub P, Kobler E, Ammann R
[Turcot syndrome--a rare extra-intestinal manifestation of familial adenomatous polyposis?]
Muller A, Meyenberger C, Hoppeler T, Spiegel R, Kaufmann U, Ammann R. [Turcot syndrome--a rare extra-intestinal manifestation of familial adenomatous polyposis?]. Schweizerische medizinische Wochenschrift 1993; 123:1125-7.
29.05.1993[Turcot syndrome--a rare extra-intestinal manifestation of familial adenomatous polyposis?]
29.05.1993Schweizerische medizinische Wochenschrift 1993; 123:1125-7
Muller A, Meyenberger Christa, Hoppeler T, Spiegel R, Kaufmann U, Ammann R
[Endosonography: progress in the diagnosis of endocrine pancreatic tumors]
Casanova C, Largiadèr F, Krestin G, Häcki W, Muller A, Wirth H, Meyenberger C, Münch R, Altorfer J, Ammann R. [Endosonography: progress in the diagnosis of endocrine pancreatic tumors]. Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1992; 81:815-8.
16.06.1992[Endosonography: progress in the diagnosis of endocrine pancreatic tumors]
16.06.1992Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1992; 81:815-8
Casanova C, Largiadèr F, Krestin G, Häcki W, Muller A, Wirth H P, Meyenberger Christa, Münch R, Altorfer J, Ammann R
[Diagnostic problems in infectious colitis in the framework of an HIV infection]
Muller A, Münch R, Meyenberger C, Altorfer J, Ammann R. [Diagnostic problems in infectious colitis in the framework of an HIV infection]. Schweizerische medizinische Wochenschrift 1992; 122:201-4.
08.02.1992[Diagnostic problems in infectious colitis in the framework of an HIV infection]
08.02.1992Schweizerische medizinische Wochenschrift 1992; 122:201-4
Muller A, Münch R, Meyenberger Christa, Altorfer J, Ammann R
[Long-term therapy of Ménétrier disease using ranitidine and pirenzepine]
Meyenberger C, Altorfer J, Münch R, Muller A, Ammann R. [Long-term therapy of Ménétrier disease using ranitidine and pirenzepine]. Schweizerische medizinische Wochenschrift 1991; 121:877-80.
08.06.1991[Long-term therapy of Ménétrier disease using ranitidine and pirenzepine]
08.06.1991Schweizerische medizinische Wochenschrift 1991; 121:877-80
Meyenberger Christa, Altorfer J, Münch R, Muller A, Ammann R